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Abstract 
 
Excessive hepatocyte apoptosis induced by bile acid accumulation occurred in severe obstructive jaundice, and impair 
the liver secretion function. The objective of this study is to determine whether the inhibition of bile acid accumulation 
through bile duct decompression affect the excessive hepatocyte apoptosis and caused improvement the liver secretion 
functions on human model. In this study we use a before and after study on severe obstructive jaundice patients due to 
extra hepatic bile duct tumor was decompressed. Bile duct decompression was performed as a model of the role of 
inhibition of bile acid accumulation inhibition bile acid accumulation and excessive hepatocyte apoptosis. Bile acid and 
marker of liver secretion functions were serially measured. Liver biopsy pre and post decompression was performed for 
Hepatocyte apoptosis pathologic examination by TUNEL fluorescing, which measured by 2 people in double blinded 
system. Total bile acid, and liver secretion functions were measured by automated chemistry analyzer. The result of 
this study shows that twenty one severe obstructive jaundice patients were included. After decompression the 
hepatocyte apoptosis index decreased from an average of 53.1 (SD 105) to 11.7 (SD 13.6) (p < 0.05). Average of bile 
acid serum decreased from 96.4 (SD 53.8) to 19.9 (SD 39.5) until 13.0 (SD 12.6) μmol/L (p < 0.05) Total bilirubin 
decreased from 20.0 (SD 8.9) to 13.3 (SD 5.0) until 6.2 (SD 4.0) mg/dL (p < 0.05), while the phosphates alkaline (ALP) 
and γ-glutamil transpeptidase (γ-GT) activities also decreased significantly. In conclusion, bile acids accumulation and 
excessive hepatocyte apoptosis through bile duct decompression improve the liver secretion functions by inhibition 
mechanism. 
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Introduction 
 
Inhibition or induction apoptosis pathways has been 
shown to be a promising targeted therapy in many 
diseases including liver diseases.1-4 Excessive 
hepatocyte apoptosis promoted by accumulation of bile 
acid will lead to hepatocellular damage, either fibrosis 
or atrophy with liver failure as its end point.5-9 
Obstructive jaundice is a human model of excessive 
hepatocyte apoptosis induced by accumulation of bile 
acid via extrinsic apoptosis pathway.10-12 Biliary duct 
decompression in obstructive jaundice animal study 
shows reduction of bile acid accumulation, hepatocyte 
apoptosis index, and stimulate hepatocytes regenera-
tion.12-14 
To date, no study has reported the role of inhibition of 
bile acid accumulation and excessive hepatocyte 
apoptosis and its subsequent effect on liver secretion 
functions in human. Obstructive jaundice model in 
animal study differs from that in human because in 
animal study obstructive jaundice occurs acutely in a 
short period.15,16 This study in human model should 
prove  this differences. 
 
Methods 
 
The study was carried out at Department of Surgery, 
Cipto Mangunkusumo Hospital and Eijkman Institute of 
Molecular Biology, Jakarta. A before and after study in 
severe obstructive jaundice patients with bile duct 
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decompression as a model of bile acid accumulation and 
excessive hepatocyte apoptosis inhibition. The inclusion 
criteria for this study were adult obstructive jaundice 
due to extra hepatic bile duct tumor (Klatskin and 
Periampullary tumor), with  total bilirubin level of more 
than 10 mg/dL, Karnofsky score of more than 70 and no 
major hematological problem. Patient was excluded if 
he/she had active hepatitis A, B or C, malignant liver 
tumor, severe liver dysfunction with massive ascetic, or 
already had bile duct decompression, and in late stage 
malignancy. 
 
Bile duct decompression was performed using a 
standard open cholecystostomy technique under local or 
general anesthesia as required. Liver biopsy for 
hepatocyte apoptosis examination was performed during 
the bile duct decompression procedure, and the second 
at the time of definitive operation for the obstructive 
jaundice causes. Hepatocytes apoptosis was identified 
using TUNEL flourescene system and the index was 
counted on 10 high power fields and was blindly 
evaluated by two independent investigators. Serum bile 
acid and bile fluid concentration, and markers of liver 
secretion functions were examined using automated 
chemistry analyzer TRX 7010 and automated chemistry 
analyzer Hitachii 911 respectively. All blood variables 
were serially measured (prior to, 7 days and 14 days, 
after decompression). Pre-decompression and post-
decompression values were then compared and analyzed 
using student’s t-test in SPSS v.16 with p < 0.05 is 
considered significant. This study followed the Helsinki 
convention and was approved by the Hospital Ethics 
Committee. This article is a part of a dissertation with 
the title Effect of the Inhibition of Bile Acid 
Accumulation and Excessive Hepatocyte Apoptosis 
Following Biliary Duct Decompression on Liver 
Functions: Study on Severe Obstructive Jaundice 
Patients, which being divided into several publications 
base on the hypothesis different.  
 
Results and Discussion 
 
The basic characteristic of the twenty one patients 
included in the study are shown in Table 1. Bile acid 
accumulation and liver functions impairment were 
identified in all patients (Table 2 and Table 3).  
 
After decompression, excessive hepatocyte apoptosis 
index decreased significantly from 53.1 (SD105) to 11.7 
(SD 13.6) (p < 0.05). Serial measurements also revealed 
significant reduction of serum bile acid from 96.4 
(SD53.8) to 19.9 (SD 39.5) to 13.0 (SD 12.6) μmol/L 
(p < 0.05), while bile fluid level increased from 987 (SD 
182) to 1400 (SD 2076) to 2087 (SD 2476) µmol/L 
(p < 0.05). The glycochenodeoxycholic (GCDC) level 
decreased in all patients from an average of 46.5 (SD 
63.7) to 6.27 (SD 14.3) and 11.4 (SD 22.0) µmol/L 
(p < 0.05).  
Total billirubin level decreased significantly from 20.0 
(SD 8.9) to 13.3 (SD 5.0) to 6.2 (SD 4.0) mg/dL 
(p < 0.05), while phosphates alkaline (ALP) and γ-
glutamil transpeptidase (γ-GT) activities also decreased 
significantly from 908 (SD 873) to 453 (SD 460) to 298 
(SD 198) IU/L (p < 0.05) and 431 (SD 421) to 222 (SD 
153) to 177 (SD 96.6) IU/L (p < 0.05). respectively. 
Aspartate aminotransferase (AST) activity decreased 
significantly from 111.8 (SD 60.6) to 110.2 (SD 101.7) 
to 72.6 (SD 36.7) IU/L (p < 0.05) while alanine 
aminotransferase (ALT) increased in the first 8 days 
from 66.7 (SD 60.3) to 72.8 (SD 78.9) and later 
decreased to 54.3 (SD 28.7) after the 21st days. The bile 
duct decompression averages were 21.3 (14-35) days. 
 
This study used a real model of severe obstructive 
jaundice patients who had bile duct decompression. It 
was a clinical study designed to determine the 
connection between biomolecular markers of the liver to 
its secretion functions which known as translational 
research.17,18 This study also prove  a basic targeted 
therapy    strategy    in    obstructive    jaundice   patients  
 
Table 1. Basic Characteristics of Patients 
 Factor                  Value  
Sex, female/male 7/14 
Age, years,Sd(range) 44±12,7 (25-71) 
Jaundice duration, months (range) 1,4(1-4) 
Decompression duration, days 
(range) 
21,3(14-35) 
Diagnosis  
Malignant 15 
Benign 6 
Definitive operation  therapy   
Curative resections 13 
Palliative operations 8 
 
 
Table 2. Basic Laboratory Findings 
Factor                  Value  
Hb (g/dL) 11.2 
Ht (%) 32.7 
WBC (1000/uL) 11.3 
Platelets (1000/uL) 260 
Ureum/Creatinin (mg/dL) 35.5/0.9 
Blood glucose (mg/dL) 104 
 
 
Table 3. Liver Secretion Function Test 
Factor                  Value  
Serum bile Acid (µmol/L) 96.4 
Serum Bilirubin (mg/dL) 20.3 
Serum ALP (IU/L) 908 
Serum γ-GT (IU/L) 431 
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Figure 1. Comparison of the Improvement of Apoptosis Index, to Bile Acid Value, and Liver Secretion Function after Bile 
Duct Decompression in Percentage,  Predecompression,  D+8,  D+21 
The hepatocyte apoptosis index magnitude decreased (∆ 74.2%) Serum bile acid magnitude decreased (∆ 79.4%) and (∆ 
86.6%), bile acid in bile fluid increased to 141.8% (∆ 41.8%) and 211.4% (∆ 111.4%). Bilirubin decreased to 66.2% (∆ 
33.8%) and 30.9% (∆ 69.1%), ALP to 49.9 (∆ 50.1%) and 32.9% (∆ 67.1%), γ-GT to 51.5 (∆ 48.5%) and 41.1% (∆ 58.9%), 
AST to 98.6 (∆ 1.4%) and 65.0% (∆ 35.0 %). ALT increased to 109.1% (∆ 9.1%) and later decreased to 81.4% (∆ 18.6%) 
 
 
management by modulating bile acid and hepatocyte 
apoptosis as the promoter of liver dysfunction in 
human.4,19 To date, no clinical study had reported the 
role of bile acid accumulation and excessive hepatocyte 
apoptosis inhibition in liver secretion functions. 
Previously, Wang et al. and Koyama et al. had 
performed similar studies in animal model.13,19 This 
earlier studies had linked hepatocytes morphological 
changes (mitochondrial respiration) and hepatocytes 
destructor bile acid to liver secretion functions in severe 
obstructive jaundice. 
 
Studies in animals usually use medication to inhibit bile 
acid accumulation and excessive hepatocyte apoptosis. 
In contrast, our study had used surgical decompression 
as a method of inhibition.1,4,8,20-23 In animal study, the 
duration of obstructive jaundice has an acute origin with 
less prominent apoptosis, compared to necrosis.13,24 The 
advantage of a human model, as was carried out in our 
study, is that the apoptosis and bile acid process in the 
model occurred chronically. 
 
Bile duct decompression which lasted for 21.3 days 
(range of 14-35 days) in our study has shown to be 
effective to influence liver secretion functions. Effective 
duration of decompression has been reported for 10-32 
days by Aronson et al.14, while Koyama et al.19 reported 
a duration of 4-6 weeks to achieve normal liver 
functions based on mitochondrial respiration. The 
purpose of bile duct decompression in obstructive 
patients is to optimize hepatocyte functions by release 
the bile acid accumulation which act as a excessive 
heaptocyte apoptosis inductor.  
Bilirubin, alkaline phosphate (ALP) and gamma 
glutamil traspeptidase (γ-GT) are the classic liver 
secretion functions which were used to confirm 
obstructive origin in jaundice patients. All of these 
markers were increase in all patients in our study and 
were considered severe according to criteria discribed by 
Pitt.25,26 The increase of these markers support the fact 
that the liver secretion functions is impaired and 
confirmed the existence of cholestasis syndrome. The 
extra-hepatic cholestasis was confirmed by the 
increased of direct bilirubin level more than indirect 
bilirubin in all patients. The variance of bilirubin level 
was similar to what was introduced by Pitt et al in 1990 
but much higher than the report in 2000 (average 14.9 vs. 
5 mg/dL) even in the era of a widespread diagnostic 
support tool.27 In obstructive jaundice due to extra 
hepatic bile duct malignancy, patient tolerance for 
radical operation should be optimized while tumor 
extension and metastasis should also come into 
consideration.27,28  
Bilirubin level fastly decreased in the first week after 
decompression, and then slowdown until it reached the 
normal value. The slowdown period is due to the 
presence of delta bilirubin which tightly binds to 
albumin and disappear following the albumin half time 
(21 days). Due to the excretion of direct bilirubin was 
also through the urine and sweat gland, so the decrease 
of its serum value cannot directly demonstrate the 
hepatocyte functions. The direct bilirubin value does not 
correlate to the grade and period of obstruction.29,30 It 
means that  prognostic value of total bilirubin was not a 
true value as we know there was no destructive effect of 
% 
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direct bilirubin. Granato et.al proved that bilirubin role as 
a bile acid inhibitor and lead lowering of hepatocyte 
apoptosis on animal study.31  
 
Bile acid concentration decreased 59% on the second 
measurement and 87% on the third measurement. After 
bile duct decompression the total bilirubin, ALP and the 
γ-GT decreased as also shown in other report 
(Figure 1).28 Not all patients reached normalization of 
ALP and γ-GT level because of a less decompression 
period and ongoing metabolic process of ALP and γ-GT 
activities at the canaliculi and hepatocyte. The halftime 
of γ-GT (26 days) which made the contribute to its 
activity and a much longer detectibility period should 
also taken into consideration, the bile duct 
decompression in this report has improve the severe 
impairment of liver secretion functions to mild grade, 
based on the criteria of Keeffe et al.32 
 
After decompression, the reduction of bile substrate 
accumulation had result in improvement of the 
hepatocyte apoptosis index 74.2% and was followed by 
the improvement of liver secretion functions capacity. 
The improvement was marked significantly by 42% 
increment of bile fluid level on the second and 111% on 
the third measurement. Improvement of liver secretion 
functions were marked by the total bilirubin level 
decrement of 34 to 69%, activity reduction of alkaline 
phosphates and γ-glutamiltranspeptidase of 50 to 67% 
and 48 to 59% respectively (Figure 1). 
 
Decreasing pattern of liver secretion functions marker in 
this study was consistent with that found in animal 
study. Rapid reduction in the first week after decom-
pression was due to reversible hepatocyte impairment, 
thus release of obstruction allowed hepatocytes to 
function properly. Slower reduction occurred because 
new hepatocytes are required for its proper function. 
These findings showed that liver functions improvement 
not only required decompression but was also 
influenced by the inhibition of bile acid 
accumulation.33,34 Reduction of AST and ALT activities 
explained that liver destruction due to apoptosis had 
been diminished after bile duct decompression.35 
 
Bile duct decompression in severe obstructive jaundice 
serves as a model of bile acid accumulation and 
excessive hepatocyte apoptosis inhibition as seen in the 
improvement of liver secretion functions. Better liver 
secretion functions  after bile duct decompression were 
supported by the increase of bile acid value in bile fluid 
from an average 987 (SD 182) to 1400 (SD 2076) to 
2087 (SD 2476) µmol/L (p < 0.05). Serum bile acid also 
decreased significantly after decompression. This 
condition confirmed that lowering the bile acid as a 
hepatocyte apoptosis inuctor will adequatly increased 
the functional hepatocyte count to overcome the liver 
secretion functions impairment.  
Bile duct decompression in severe obstructive jaundice 
inhibit the bile acid accumulation including the primary 
bile acid such Glycochenodeoxycholate (GCDC) 
accumulation. The reduction of GCDC led to 
diminution of apoptosis index as be known that GCDC 
was  the inductor hepatocyte apoptosis via the extrinsic 
pathway (Figure 1). The lowering of bile acid was 
similar to the classic value of liver secretion functions 
improvement after bile duct decompression in this study 
and appropriate with other report.33 
 
Liver dysfunction is one of the surgical risk factors in 
severe obstructive jaundice that increase morbidity and 
mortality. This study found that liver dysfunction due to 
accumulation of bile acid and excessive hepatocyte 
apoptosis could be inhibited by decompression of bile 
duct. Therefore, inhibition of accumulation of bile acid 
and excessive hepatocyte apoptosis by bile duct decom-
pression might lower risk, morbidity, and mortality of 
patients presenting with severe obstructive jaundice. 
 
Conclusions 
 
Inhibition of bile acids accumulation and excessive 
hepatocyte apoptosis through bile duct decompression 
improved the liver secretion functions. Recovery of 
liver secretion functions were adequately achieved in 
three weeks period of bile duct decompression, so it is 
accepted as a treatment option in obstructive jaundice 
patient. 
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